Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SFXN3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | MYLK2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | ATF4 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | FBRS | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | EIF3G | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | PSG5 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | HHLA2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | GRM5 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | SLC16A2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | OR52E4 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |